Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

ILK is essential for skin development, pigmentation, and healing.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Removing SIX1 in fat cells reduces skin fibrosis.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Skin inflammation can worsen intestinal inflammation and colitis.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

RNase L hinders hair growth by altering immune signals.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.